Verma, Aditya http://orcid.org/0000-0003-3778-8834
Magesan, Kowsigan
Amose, T
Alagorie, Ahmed Roshdy
Gnanaraj, Ramya
Sadda, SriniVas R.
Sen, Parveen http://orcid.org/0000-0003-2256-9380
Article History
Received: 17 October 2021
Revised: 9 March 2022
Accepted: 13 June 2022
First Online: 11 August 2022
Competing interests
: SRS has the following financial disclosures: Consultant: Amgen, Allergan, Genentech/Roche, Iveric, Oxurion, Novartis, Regeneron, Bayer, 4DMT, Centervue, Heidelberg, Optos, Merck, Apellis, Astellas; Speaker Fees: Carl Zeiss Meditec, Nidek; Research Instruments: Nidek, Topcon, Heidelberg, Carl Zeiss Meditec, Optos, Centervue. The authors declare no competing interests.